Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Glioblastoma 16Glioma 14Neoplasms 13Breast Neoplasms 13Prostatic Neoplasms 12Brain Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 8Lymphoma, B-Cell 8Pancreatic Neoplasms 7Multiple Myeloma 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Recurrence 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Skin Neoplasms 4Lymphoma 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Lung Neoplasms 3Colonic Neoplasms 3Astrocytoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Dendritic Cell Sarcoma, Interdigitating × 90 days × Clear all
NCT07548697 2026-04-23

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase EARLY_PHASE1 Recruiting
24 enrolled
LymphoidSarcoma

Lymphoma, Follicular, Lymphoma, B-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡